表紙
市場調查報告書

乾眼症治療藥的全球市場:產業分析,市場規模、佔有率、成長率、趨勢、預測 (2020∼2030年)

Dry Eye Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030

出版商 Transparency Market Research 商品編碼 953644
出版日期 內容資訊 英文 214 Pages
商品交期: 最快1-2個工作天內
價格
乾眼症治療藥的全球市場:產業分析,市場規模、佔有率、成長率、趨勢、預測 (2020∼2030年) Dry Eye Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030
出版日期: 2020年06月18日內容資訊: 英文 214 Pages
簡介

本報告提供全球乾眼症治療藥的市場相關分析,市場基本結構和主要的影響要素,市場規模趨勢預測 (過去2年、今後11年份),各產品、各疾病、各流通管道及各地區詳細趨勢,競爭環境 (市場佔有率結構),主要企業簡介等調查。

目錄

第1章 序文

第2章 前提條件與分析方法

第3章 摘要整理:全球乾眼症治療藥市場

第4章 市場概要

  • 簡介
    • 種類定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 全球乾眼症治療藥市場分析、預測 (2018∼2030年)
    • 市場收益額的預測 (以金額為準)
  • 波特的五力分析

第5章 主要洞察

  • 全球乾眼症治療藥市場:主要的企業合併、收購 (M&A)
  • 開發平台分析
  • 全球主要國家的疾病的得病率和發生率
  • 技術進步
  • 新型冠狀病毒感染疾病 (COVID-19)的對產業的影響 (短期/中期/長期性影響)

第6章 全球乾眼症治療藥市場分析、預測:各產品

  • 簡介和定義
  • 市場規模的預測:各產品 (2018∼2030年)
    • 人工淚液
    • 抗發炎藥
    • 淚點塞
    • 秘書
    • 分泌催化劑
  • 市場向心力分析:各產品

第7章 全球乾眼症治療藥市場分析、預測:各疾病

  • 簡介和定義
  • 市場規模的預測:各疾病 (2018∼2030年)
    • 汽化亢進型乾眼症症候群
    • 淚液減少型乾眼症症候群
  • 市場向心力分析:各疾病

第8章 全球乾眼症治療藥市場分析、預測:各流通管道

  • 簡介和定義
  • 市場規模的預測:各流通管道 (2018∼2030年)
    • 醫院藥局
    • 零售藥局
    • 線上藥局
  • 市場向心力分析:各流通管道

第9章 全球乾眼症治療藥市場分析、預測:各地區

  • 主要調查結果
  • 市場規模的預測:各地區
    • 北美
    • 歐洲
    • 亞太地區市場
    • 南美
    • 中東、非洲
  • 市場向心力分析:各地區

第10章 北美的乾眼症治療藥市場分析、預測

  • 簡介
    • 主要調查結果
  • 市場規模的預測:各產品 (以金額為準,2018∼2030年)
  • 市場規模的預測:各疾病 (以金額為準,2018∼2030年)
  • 市場規模的預測:各流通管道 (以金額為準,2018∼2030年)
  • 市場規模的預測:各國 (以金額為準,2018∼2030年)
    • 美國
    • 加拿大
  • 北美的乾眼症治療藥市場:向心力分析

第11章 歐洲的乾眼症治療藥市場分析、預測

第12章 亞太地區的乾眼症治療藥市場分析、預測

第13章 南美的乾眼症治療藥市場分析、預測

第14章 中東、非洲的乾眼症治療藥市場分析、預測

第15章 競爭情形

  • 市場參與企業:競爭矩陣(企業各等級、各規模)
  • 市場佔有率/地位分析:各企業 (2018年)
  • 各企業的商務策略
  • 企業簡介
    • Novartis AG
    • Allergan
    • 參天製藥
    • OASIS Medical
    • Sun Pharmaceutical Industries Ltd.
    • Johnson & Johnson
    • 大塚製藥
    • Sentiss Pharma Pvt. Ltd.
    • RegeneRx (ReGenTree, LLC)
    • Bausch Health Companies, Inc.
目錄
Product Code: TMRGL77640

Title:
Dry Eye Disease Treatment Market (Product: Artificial Tears, Anti-inflammatory [Cyclosporine, Corticosteroid, and Others], Punctal Plugs, Secretagogue, and Others; Disease: Evaporative Dry Eye Syndrome and Aqueous Dry Eye Syndrome; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2030.

Scope of the Report

TMR's report on the global dry eye disease treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global dry eye disease treatment market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global dry eye disease treatment market during the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the global dry eye disease treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, companies' presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global dry eye disease treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global dry eye disease treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global dry eye disease treatment market.

The report delves into the competition landscape of the global dry eye disease treatment market. Key players operating in the global dry eye disease treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global dry eye disease treatment market that have been profiled in this report.

Key Questions Answered:

  • What is the scope of growth of the anti-inflammatory segment of the global dry eye disease treatment market?
  • What will be the Y-o-Y growth of the global dry eye disease treatment market between 2020 and 2030?
  • What is the influence of changing trends in cyclosporine on the global dry eye disease treatment market?
  • Will North America continue to be the most profitable market for dry eye disease drug providers?
  • Which factors are anticipated to hamper the growth of the global dry eye disease treatment market during the forecast period?
  • Which are the leading companies in the global dry eye disease treatment market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global dry eye disease treatment market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global dry eye disease treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR's study on the global dry eye disease treatment market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the dry eye disease treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global dry eye disease treatment market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR's estimates on future prospects of the global dry eye disease treatment market more reliably and accurately.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dry Eye Disease Treatment Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018-2030
    • 4.4.1. Market Revenue Projections (US$ Mn)
  • 4.5. Porter's Five Force Analysis

5. Key Insights

  • 5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions
  • 5.2. Pipeline Analysis
  • 5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
  • 5.4. Technological Advancement
  • 5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)

6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product

  • 6.1. Introduction & Definition
    • 6.1.1. Key Findings / Developments
  • 6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018-2030
    • 6.2.1. Artificial Tears
    • 6.2.2. Anti-inflammatory
      • 6.2.2.1. Cyclosporine
      • 6.2.2.2. Corticosteroid
      • 6.2.2.3. Others
    • 6.2.3. Punctal Plugs
    • 6.2.4. Secretagogue
    • 6.2.5. Others
  • 6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product

7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease

  • 7.1. Introduction & Definition
    • 7.1.1. Key Findings / Developments
  • 7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018-2030
    • 7.2.1. Evaporative Dry Eye Syndrome
    • 7.2.2. Aqueous Dry Eye Syndrome
  • 7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease

8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
    • 8.1.1. Key Findings / Developments
  • 8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018-2030
    • 8.2.1. Hospital Pharmacies
    • 8.2.2. Retail Pharmacies
    • 8.2.3. Online Pharmacies
  • 8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel

9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region

10. North America Dry Eye Disease Treatment Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 10.2.1. Artificial Tears
    • 10.2.2. Anti-inflammatory
      • 10.2.2.1. Cyclosporine
      • 10.2.2.2. Corticosteroid
      • 10.2.2.3. Others
    • 10.2.3. Punctal Plugs
    • 10.2.4. Secretagogue
    • 10.2.5. Others
  • 10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 10.3.1. Evaporative Dry Eye Syndrome
    • 10.3.2. Aqueous Dry Eye Syndrome
  • 10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Retail Pharmacies
    • 10.4.3. Online Pharmacies
  • 10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis
    • 10.6.1. By Product
    • 10.6.2. By Disease
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Dry Eye Disease Treatment Market Analysis and Forecast

  • 11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 11.1.1. Artificial Tears
    • 11.1.2. Anti-inflammatory
      • 11.1.2.1. Cyclosporine
      • 11.1.2.2. Corticosteroid
      • 11.1.2.3. Others
    • 11.1.3. Punctal Plugs
    • 11.1.4. Secretagogue
    • 11.1.5. Others
  • 11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 11.2.1. Evaporative Dry Eye Syndrome
    • 11.2.2. Aqueous Dry Eye Syndrome
  • 11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 11.3.1. Hospital Pharmacies
    • 11.3.2. Retail Pharmacies
    • 11.3.3. Online Pharmacies
  • 11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 11.4.1. Germany
    • 11.4.2. U.K.
    • 11.4.3. France
    • 11.4.4. Spain
    • 11.4.5. Italy
    • 11.4.6. Rest of Europe
  • 11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Disease
    • 11.5.3. By Distribution Channel
    • 11.5.4. By Country/Sub-region

12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast

  • 12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 12.1.1. Artificial Tears
    • 12.1.2. Anti-inflammatory
      • 12.1.2.1. Cyclosporine
      • 12.1.2.2. Corticosteroid
      • 12.1.2.3. Others
    • 12.1.3. Punctal Plugs
    • 12.1.4. Secretagogue
    • 12.1.5. Others
  • 12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 12.2.1. Evaporative Dry Eye Syndrome
    • 12.2.2. Aqueous Dry Eye Syndrome
  • 12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 12.3.1. Hospital Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 12.4.1. China
    • 12.4.2. Japan
    • 12.4.3. India
    • 12.4.4. Australia & New Zealand
    • 12.4.5. Rest of Asia Pacific
  • 12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Disease
    • 12.5.3. By Distribution Channel
    • 12.5.4. By Country/Sub-region

13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast

  • 13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 13.1.1. Artificial Tears
    • 13.1.2. Anti-inflammatory
      • 13.1.2.1. Cyclosporine
      • 13.1.2.2. Corticosteroid
      • 13.1.2.3. Others
    • 13.1.3. Punctal Plugs
    • 13.1.4. Secretagogue
    • 13.1.5. Others
  • 13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
    • 13.2.1. Evaporative Dry Eye Syndrome
    • 13.2.2. Aqueous Dry Eye Syndrome
  • 13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 13.3.1. Hospital Pharmacies
    • 13.3.2. Retail Pharmacies
    • 13.3.3. Online Pharmacies
  • 13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 13.4.1. Brazil
    • 13.4.2. Mexico
    • 13.4.3. Rest of Latin America Latin America
  • 13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis
    • 13.5.1. By Product
    • 13.5.2. By Disease
    • 13.5.3. By Distribution Channel
    • 13.5.4. By Country/Sub-region

14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast

  • 14.1.1.
  • 14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 14.2.1. Artificial Tears
    • 14.2.2. Anti-inflammatory
      • 14.2.2.1. Cyclosporine
      • 14.2.2.2. Corticosteroid
      • 14.2.2.3. Others
    • 14.2.3. Punctal Plugs
    • 14.2.4. Secretagogue
    • 14.2.5. Others
  • 14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
    • 14.3.1. Evaporative Dry Eye Syndrome
    • 14.3.2. Aqueous Dry Eye Syndrome
  • 14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Retail Pharmacies
    • 14.4.3. Online Pharmacies
  • 14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis
    • 14.6.1. By Product
    • 14.6.2. By Disease
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competitive Landscape

  • 15.1. Market Player - Competition Matrix (by Tier and Size of companies)
  • 15.2. Market Share / Position Analysis, by Company, 2018
  • 15.3. Competitive Business Strategies
  • 15.4. Company Profiles
    • 15.4.1. Novartis AG
      • 15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.1.2. Growth Strategies
      • 15.4.1.3. SWOT Analysis
    • 15.4.2. Allergan
      • 15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.2.2. Growth Strategies
      • 15.4.2.3. SWOT Analysis
    • 15.4.3. Santen Pharmaceutical Co., Ltd.
      • 15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.3.2. Growth Strategies
      • 15.4.3.3. SWOT Analysis
    • 15.4.4. OASIS Medical
      • 15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.4.2. Growth Strategies
      • 15.4.4.3. SWOT Analysis
    • 15.4.5. Sun Pharmaceutical Industries Ltd.
      • 15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.5.2. Growth Strategies
      • 15.4.5.3. SWOT Analysis
    • 15.4.6. Johnson & Johnson
      • 15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.6.2. Growth Strategies
      • 15.4.6.3. SWOT Analysis
    • 15.4.7. Otsuka Pharmaceutical Co., Ltd.
      • 15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.7.2. Growth Strategies
      • 15.4.7.3. SWOT Analysis
    • 15.4.8. Sentiss Pharma Pvt. Ltd.
      • 15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.8.2. Growth Strategies
      • 15.4.8.3. SWOT Analysis
    • 15.4.9. RegeneRx (ReGenTree, LLC)
      • 15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.9.2. Growth Strategies
      • 15.4.9.3. SWOT Analysis
    • 15.4.10. Bausch Health Companies, Inc.
      • 15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.4.10.2. Growth Strategies
      • 15.4.10.3. SWOT Analysis

List of Tables

  • Table 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018-2030
  • Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018-2030
  • Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030
  • Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018-2030
  • Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018-2030
  • Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018-2030
  • Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018-2030
  • Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018-2030

List of Figures

  • Figure 01: Global Dry Eye Disease Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2030
  • Figure 02: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 03: Global Dry Eye Disease Treatment Market Value Share (%), by Product, 2019
  • Figure 04: Global Dry Eye Disease Treatment Market Value Share (%), by Disease, 2019
  • Figure 05: Global Dry Eye Disease Treatment Market Value Share (%), by Distribution Channel, 2019
  • Figure 06: Global Dry Eye Disease Treatment Market Value Share (%), by Region, 2019
  • Figure 07: Global Dry Eye Disease Treatment Market Value Share Analysis (%), by Product, 2019 and 2030
  • Figure 08: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 09: Global Dry Eye Disease Treatment Market Value Share (%), by Anti-inflammatory, 2019 and 2030
  • Figure 10: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Tears, 2018-2030
  • Figure 11: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-inflammatory, 2018-2030
  • Figure 12: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secretagogue, 2018-2030
  • Figure 13: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Punctal Plugs, 2018-2030
  • Figure 14: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018-2030
  • Figure 15: Global Dry Eye Disease Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030
  • Figure 16: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 17: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Evaporative Dry Eye Syndrome, 2018-2030
  • Figure 18: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aqueous Dry Eye Syndrome, 2018-2030
  • Figure 19: Global Dry Eye Disease Treatment Market Value Share (%)Analysis, by Distribution Channel, 2019 and 2030
  • Figure 20: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 21: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018-2030
  • Figure 22: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018-2030
  • Figure 23: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018-2030
  • Figure 24: Global Dry Eye Disease Treatment Market Value Share Analysis, by Region, 2019 and 2030
  • Figure 25: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Region, 2020-2030
  • Figure 26: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 27: North America Dry Eye Disease Treatment Market Value Share Analysis, by Country, 2019 and 2027
  • Figure 28: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country, 2020-2030
  • Figure 29: North America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 30: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 31: North America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 32: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 33: North America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 34: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 35: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 36: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
  • Figure 37: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 38: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 39: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 40: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 41: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 42: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 43: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 44: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 45: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 46: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 47: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 48: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 49: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 50: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 51: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 52: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 53: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 54: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 55: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 56: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 57: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 58: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 59: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 60: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 61: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030
  • Figure 62: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018-2030
  • Figure 63: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
  • Figure 64: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020-2030
  • Figure 65: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
  • Figure 66: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020-2030
  • Figure 67: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
  • Figure 68: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020-2030
  • Figure 69: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
  • Figure 70: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020-2030